AI optimizes existing knowledge but doesn't expedite drug approval or reduce costs compared to traditional methods. Explore ...

IQVIA, Illumina, Mayo Clinic and Arc Institute Harness NVIDIA AI and Accelerated Computing to Transform $10 Trillion ...

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies.

CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, today announced it has entered into a strategic partnership with ...

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

With the advent of machine learning and artificial intelligence, materials science could be poised to take its next big leap ...

A groundbreaking study led by Nobel Laureate David Baker and Timothy Patrick Jenkins introduces innovative, computationally ...

A partnership with biotechnology firm Illumina Inc. aims to unlock insights from genomics data by combining Illumina’s ...

The AI-designed proteins neutralized lethal 3FTx toxins found in snake venom, which are often the reason that traditional antivenoms fail.

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...